Search

everythinglearnresearchcommunity

for

Search:↓

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Olorofim effectively treats fungal skin infections.

Cepharanthine shows promise as a COVID-19 treatment.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

DFMO may help control hair growth and treat cancer.

Fluconazole-loaded hair gel may offer a longer-lasting dandruff treatment.

Plantain leaf extract reduces liver oxidative stress in malaria-infected mice.

Nail loss may be a side effect of the MS drug teriflunomide.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Trimethoprim-sulfamethoxazole can cause aseptic meningitis.

Griseofulvin effectively treats tinea capitis in infants.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Topical metformin effectively treats melasma with minimal side effects.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Improving medical training is key to eradicating frambusia by 2030.

Both new medications and non-drug treatments can effectively manage migraines with fewer side effects.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.